Alpha-GPC, a choline-rich supplement, enhances brain health by increasing acetylcholine, with potential applications in ...

Now, scientists in Korea have discovered that the Parkinson’s disease drug procyclidine can alleviate physical symptoms of ...

by existing clinically prescribed neuroactive drugs. This scenario opens exciting new possibilities for the treatment of neurodegenerative diseases. In particular, the finding that acetylcholine ...

A new study from the University of East Anglia has found that long-term use of certain antidepressants may increase the risk of dementia, even if taken up to 20 years before a diagnosis. The study ...

Milestone payment triggered by the initiation of a Phase 2 clinical trial in Alzheimer’s disease with MK-1167, an α7 ...

In other words, "the cannabinoid receptors were seen to be activated and the acetylcholine levels in the brain to be increased. The drug restored the cholinergic system and improved memory", added ...

The neurotransmitter acetylcholine is responsible for learning ... that was tested and saw no side effects typical of other drugs working on the same area of the brain. Following this successful ...

BURLINGTON, Mass. - Neuphoria Therapeutics Inc. (NASDAQ:NEUP), a biotechnology firm focused on neuropsychiatric treatments with a market capitalization of $7.27 million, is set to receive a $15 ...

Neuphoria Therapeutics Inc. (Nasdaq: NEUP) (Neuphoria or Company), a late-stage biotechnology developing impactful treatments for neuropsychiatric ...

Acetylcholine is a neurotransmitter that helps to activate muscles and causes them ... Heintz noted, for example, that more work is needed to determine whether lynx1 or its family members will be ...